Studies on using NGS technology for NPC Screening| Take2 Health

Our Technologies

clinical papers banner

Relevant Studies and Literature

The Take2 Prophecy™ Test for NPC utilises the pioneering technology invented by an award-winning research team from the Chinese University of Hong Kong (CUHK). The technologies has been validated by large-scale clinical study involving 20,000 individuals and the research was published in the globally respected New England Journal of Medicine and Proceedings of the National Academy of Sciences of the United States of America. The reports and results can be viewed here:

Follow Us
©2023 Take2 Health All Rights Reserved
Privacy PolicyTerms of UsePersonal Information Collection Statement